<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Shengxing</forename><surname>Zhu</surname></persName>
							<email>shengxing_zhu@sina.com</email>
							<affiliation key="aff1">
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">The First Affiliated Hospital of Zhengzhou University</orgName>
								<address>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of The Second General Surgery</orgName>
								<orgName type="institution">People&apos;s Hospital of Zhengzhou</orgName>
								<address>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jihua</forename><surname>Shi</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">The First Affiliated Hospital of Zhengzhou University</orgName>
								<address>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shanfeng</forename><surname>Zhang</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">School of Basic Medicine</orgName>
								<orgName type="institution">Zhengzhou University</orgName>
								<address>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhen</forename><surname>Li</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Gastrointestinal Surgery</orgName>
								<orgName type="institution">The First Affiliated Hospital of Zhengzhou University</orgName>
								<address>
									<settlement>Zhengzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">The First Affiliated Hospital of Zhengzhou University</orgName>
								<address>
									<postCode>450000</postCode>
									<settlement>Zhengzhou</settlement>
									<region>Henan</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<idno type="ISSN">p 2093-582X</idno>
					</monogr>
					<idno type="MD5">8E7F7D5C6BD159D204938043E5797922</idno>
					<idno type="DOI">10.5230/jgc.2018.18.e35</idno>
					<note type="submission">Received: Sep 3, 2018 Revised: Nov 2, 2018 Accepted: Nov 4, 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:33+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Gastric cancer</term>
					<term>KLK6 protein, human</term>
					<term>MMP9 protein, human</term>
					<term>VEGF Author Contributions Conceptualization: Z.S., L.Z.</term>
					<term>Funding acquisition: L.Z.</term>
					<term>Investigation: Z.S., Z.S.</term>
					<term>Resources: S.J.</term>
					<term>Writing -original draft: Z.S., L.Z.</term>
					<term>Writing -original draft: Z.S., L.Z</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Purpose: Kallikrein (KLK) proteases are hormone-like signaling molecules with critical functions in different cancers.</s><s>This study investigated the expression of KLK6 in gastric cancer and its potential role in the growth, migration, and invasion of gastric cancer cells.</s><s>Materials and Methods: In this study, we compared protein levels of KLK6, vascular endothelial growth factor (VEGF), and matrix metallopeptidase (MMP) 9 in normal gastric epithelial and gastric cancer cell lines by western blot.</s><s>Fluorescence-activated cell sorting was employed to sort 2 clones of SGC-7901 cells with distinct KLK6 expression, namely, KLK6-high (KLK6 high ) and KLK6-low (KLK6 low ), which were then expanded.</s><s>Lastly, immunohistochemical analysis was performed to investigate KLK6 expression in gastric cancer patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results:</head><p><s>The expression levels of KLK6, VEGF, and MMP 9, were significantly higher in the gastric cancer cell lines SGC-7901, BGC-823, MKN-28, and MGC-803 than in the normal gastric epithelial cell line GES-1.</s><s>Compared to KLK6 low cells, KLK6 high cells showed enhanced viability, colony-forming ability, migration, and invasion potential in vitro.</s><s>Importantly, immunohistochemical analysis of a human gastric cancer tissue cohort revealed that the staining for KLK6, VEGF, and MMP9 was markedly stronger in the cancerous tissues than in the adjacent normal tissues.</s><s>KLK6 expression also correlated with that of VEGF and MMP9 expression, as well as several key clinicopathological parameters.</s><s>Conclusions: Together, these results suggest an important role for KLK6 in human gastric cancer progression.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>The human tissue kallikreins (KLKs), consisting of 15 members, are involved in tissue-specific proteolysis of numerous endogenous substrates <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>It is an important family of serine proteases that are involved in various processes in both healthy and diseased states, including a number of cancers <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>For instance, KLK4 plays a critical role in promoting prostate cancer progression by integrating androgen and mammalian target of rapamycin signaling network In this study, we first observed that the expression level of KLK6 in 4 different gastric cancer cell lines was significantly higher than that in the normal gastric epithelial cells.</s><s>A similar expression pattern was also observed for vascular endothelial growth factor (VEGF) and matrix metallopeptidase (MMP) 9, 2 critical players known to promote invasion and metastasis <ref type="bibr" target="#b25">[14,</ref><ref type="bibr" target="#b27">15]</ref>.</s><s>We then sorted SGC-7901 cells into clones with distinct KLK6 expression and selected 2 clones KLK6-high (KLK6 high ) and KLK6-low (KLK6 low ).</s><s>Functional assays revealed that KLK6 high SGC-7901 cells displayed higher potential for migration and invasion in vitro, relative to KLK6 low cells.</s><s>Lastly, immunostaining of a large human gastric cancer tissue cohort revealed that the expression of KLK6 positively correlated with that of VEGF, MMP9, as well as several clinicopathological parameters.</s><s>Together, these data suggest an important role for KLK6 in promoting growth, migration, and invasion of gastric cancer cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>Gastric cancer cell lines SGC-7901, BGC-823, MGC-803, and MKN-28 and the normal gastric epithelial cell line GES-1 were routinely cultured in Roswell Park Memorial Institute 1640 medium containing 10% fetal calf serum supplemented with 50 U/mL penicillin, 50 lg/mL streptomycin, and 2 mM L-glutamine in a humidified chamber with 5% CO 2 at 37°C.</s><s>All reagents were purchased from Hyclone (GE Healthcare, Chicago, IL, USA).</s><s>All cell lines were routinely tested and were negative for mycoplasma contamination.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical samples</head><p><s>Gastric cancer tissue samples from 326 patients were collected at the People's Hospital of Zhengzhou between March 2005 and March 2011.</s><s>Prior to surgery, all patients were free of distant metastases, and had not received chemotherapy, radiotherapy, or immunotherapy.</s><s>A part of the collected tissues was fixed in 4% paraformaldehyde for immunohistochemical analysis, and the other part was preserved at −80°C.</s><s>The adjacent normal tissues were collected from sites at least 5 cm away from the tumor margins, which were further confirmed by pathological analysis.</s><s>The detailed information of patients is shown in</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RNA extraction, complementary DNA (cDNA) synthesis, and quantitative polymerase chain reaction (qPCR)</head><p><s>Total RNA from cells or frozen gastric tissues was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol.</s><s>RNA concentration was measured using the Nanodrop ND-1000 spectrophotometer and RNA quality was verified by agarose gel electrophoresis.</s><s>The cDNA synthesis was performed using SuperScript II Reverse Transcriptase (Invitrogen), which was then used as a template for qPCR analysis performed using SYBR green dye (Applied Biosystems, Foster City, CA, USA) and LightCycler 480 system (Roche, Basel, Switzerland).</s><s>The sequences of the primers used are available upon request.</s><s>GAPDH gene expression was used for normalization.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blot analysis</head><p><s>Cell or tissue extracts were prepared, and protein concentration was measured using the bicinchoninic acid assay.</s><s>Primary antisera against KLK6 (ab190924), MMP9 (ab137867), and VEGFA (ab51745) were all purchased from Abcam (Cambridge, UK) and used at a dilution of 1:1,000.</s><s>The secondary antiserum (Thermo Fisher Scientific, Waltham, MA, USA) was used according to the manufacturer's instructions at a dilution of 1:4,000.</s><s>ECL substrate kit (ZSBio, Beijing, China) was used for the detection of proteins.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fluorescence-activated cell sorting (FACS) assay</head><p><s>Flow cytometry was performed on BD FACSCalibur flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) using CellQuest (Largo, FL, USA) and the data were analyzed with FlowJo V10.2 software (Tree Star Inc., San Carlos, CA, USA).</s><s>KLK6 antibody was diluted in phosphate-buffered saline containing 0.1% bovine serum albumin (Sigma-Aldrich, St. Louis, MO, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry</head><p><s>Immunohistochemistry was performed using the SP kit (SPN-9002) (ZSBio) according to the manufacturer's guidelines.</s><s>Primary antibodies against KLK6 (ab190924), MMP9 (ab137867), and VEGFA (ab51745) were all purchased from Abcam, and used at a dilution of 1:50.</s><s>The immunohistochemical images were quantified.</s><s>Five fields of view were randomly selected on each section (with at least 200 cells per view), and the quantification was performed as follows: Score A was assigned according to the proportion of positively-stained cells: 0 for &lt;5%, 1 for 6%-25%, 2 for 26%-50%, 3 for 51%-75%, and 4 for &gt;75%.</s><s>An independent score B was assigned according to the intensity of staining: 0 for negative, 1 for moderate, 2 for strong, and 3 for very strong.</s><s>A final score was then calculated according to the formula, score C = score A × score B. Eventually, samples with a score C above 5 were considered positive, while samples with a score C below 5 were considered negative.</s></p><formula xml:id="formula_0">358 https://jgc-</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methyl thiazolyl tetrazolium (MTT) assay</head><p><s>Cells were seeded in 96-well plates (5×10 3 cells per well) and cultured in normal growth media up to 72 hours.</s><s>The MTT reagent (Sigma-Aldrich) was used according to the manufacturer's instructions.</s><s>Three experiments were performed separately in quadruplicates and the representative results are shown.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Colony formation assay</head><p><s>Approximately 2,000 cells were seeded in 6-cm plates and cultured in normal growth media.</s><s>After 2 weeks, the colonies were fixed with cold methanol, and visualized using 0.5 mL of 0.01% crystal violet and photographed.</s><s>The experiment was repeated 3 times in triplicate.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Wound healing assay</head><p><s>SGC-7901 cells (5×10 5 ) were cultured as confluent monolayers in a 6-well plate.</s><s>After attaining 100% confluency, the cell layer was scratched by removing a strip of cells across the well using a 200 µL pipette tip.</s><s>The scratched monolayers were then washed twice to remove non-adherent cells.</s><s>The wells were photographed using a cell imaging system at 4× magnification, at 0, 24, and 48 hours after the scratch.</s><s>The experiment was performed in triplicates and the images were analyzed using Image J software.</s><s>Error bars in the figure represent the standard deviation.</s><s>Statistical significance was determined by Student's t-test, with P&lt;0.05 considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Invasion assay</head><p><s>Cells were cultured in complete culture medium, grown to 70% confluency, harvested, and suspended in serum-free medium.</s><s>Inserts were pre-coated with 100 µL Matrigel (Corning Inc., New York, NY, USA) 24 hours prior to conducting the assay.</s><s>Cells (2×10 4 ) were seeded in each insert and media was added in the lower chamber.</s><s>After 48 hours of incubation, the inserts were fixed and stained, and the number of invaded tumor cells was counted under a microscope.</s><s>Ten fields of view were randomly counted for each insert and the assay was performed in triplicate.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical comparisons were analyzed using SPSS 17.0 software (IBM Corp., Armonk, NY, USA).</s><s>Immunohistochemical results were analyzed using χ 2 test.</s><s>Spearman's rank correlation was used for concordant expression analysis and other data was analyzed using analysis of variance.</s><s>A value of P&lt;0.05 was considered as statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Expression of KLK6, VEGF, and MMP9 in gastric cancer and normal gastric epithelial cells</head><p><s>We first assessed the protein expression of KLK6 in a panel of 4 different gastric cancer cell lines SGC-7901, BGC-823, MKN-28, and MGC-803, and 1 normal gastric epithelial cell line GES-1, by western blotting.</s><s>Our results showed that KLK6 expression was markedly higher in the cancer cells compared to the normal cell line, with the highest expression in SGC-7901 cells (Fig. <ref type="figure">1</ref>).</s><s>Meanwhile, the expression levels of VEGF and MMP9, 2 well-established pro-metastasis factors, displayed a similar pattern and largely correlated with that of KLK6 (Fig. <ref type="figure">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparison of in vitro growth, migration, and invasion potential between KLK6 high and KLK6 low gastric cancer cells</head><p><s>Considering the heterogeneity of cancer cells, we first tried to sort SGC-7901 cells according to KLK6 expression using FACS.</s><s>Both KLK6 high and KLK6 low expressing clones were obtained.</s><s>This was validated by western blot analysis, where a marked difference was observed in KLK6 and VEGF expression (Fig. <ref type="figure">2A</ref>).</s><s>We then expanded these clones and performed the MTT assay, where KLK6 high cells showed drastically higher viability and proliferation rate relative to KLK6 low cells over a period of 72 hours (Fig. <ref type="figure">2B</ref>).</s><s>Simultaneously, KLK6 high cells also exhibited a 2-fold increase in the clonogenic ability compared to KLK6 low cells (Fig. <ref type="figure">2C</ref>).</s><s>These results suggested that KLK6 promotes gastric cancer cell growth in vitro.</s></p><p><s>To compare the migration ability of these cells, the wound healing assay was performed.</s></p><p><s>As shown in Fig. <ref type="figure" target="#fig_1">3</ref>, KLK6 high cells migrated significantly faster than KLK6 low cells and the wound of KLK6 high cells healed almost completely after 48 hours.</s><s>To further assess the invasive potential of these cells, we conducted transwell invasion assay, where significantly more KLK6 high cells invaded through the matrigel-coated insert within 24 hours compared to the KLK6 low cells (Fig. <ref type="figure" target="#fig_2">4</ref>).</s><s>These data suggested that KLK6 high SGC-7901 cells have greater migration and invasion potential in vitro, compared to the KLK6 low cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Expression analysis of KLK6, VEGF, and MMP9 in gastric cancer tissues and normal tissues</head><p><s>To further gain insight into the role of KLK6 in human gastric cancer, we first randomly selected 10 patient samples from a cohort consisting of 326 gastric tumor tissues and their matching neighboring normal tissues.</s><s>The qPCR and western blot analyses showed that both messenger RNA (mRNA) and protein expression levels of KLK6, VEGF, and MMP9 were significantly higher in cancer tissues relative to their adjacent normal tissues (Fig. <ref type="figure" target="#fig_3">5A</ref>).</s><s>Next, we performed immunohistochemical analysis of KLK6, VEGF, and MMP9 in the same cohort.</s><s>As shown in Fig. <ref type="figure" target="#fig_3">5B</ref>, KLK6, VEGF, and MMP9 were all predominantly expressed in the cytoplasm of cancer cells, whereas membrane and extracellular staining of KLK6 and MMP9 could also be observed occasionally.</s><s>Consistent with the qPCR and western blot results, all of these proteins displayed stronger staining intensity in cancer tissues compared to that in the normal tissues.</s><s>Table <ref type="table" target="#tab_4">2</ref> represents significant difference (P&lt;0.01) in the number of positively-stained samples between tumor and normal tissues.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Correlation of KLK6 expression with that of VEGF and MMP9 in human gastric cancer</head><p><s>In this cohort, 100 patient samples showed positive staining for both KLK6 and VEGF, while 111 patient samples were negatively stained for both; 125 patient samples showed positive staining for both KLK6 and MMP9, while 71 patient samples were negative for both.</s><s>According to Spearman's correlation analysis, the expression of KLK6 was significantly associated with the expression levels of VEGF and MMP9 in this cohort (P&lt;0.01;</s><s>Table <ref type="table" target="#tab_5">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association of KLK6 expression with clinicopathological parameters of gastric cancer</head><p><s>When cross-referencing the immunostaining results of KLK6 expression with patient survival data, we found that patients with negative KLK6 expression (KLK6 − ) had significantly better survival rate compared to those patients with positive KLK6 expression (KLK6 + ) (χ 2 =6.534,</s><s>P=0.008; Fig. <ref type="figure" target="#fig_3">5C</ref>).</s><s>Further analyses of KLK6 expression with respect to pathological tumor, node, and metastasis (TNM) staging showed that 50% of the phase III patients (65/130) were KLK6 + , which was significantly higher compared to patients either in phase II (48/114) or phase I (27/82) (P=0.027).</s><s>In addition, the probability of KLK6 + patients to develop lymph node metastases was 52.94% (72/136), significantly higher than that of lymph  node metastases-free patients (36.84%, 70/190) (P=0.004).</s><s>In contrast, no significant correlation was observed between KLK6 expression and age, gender, or the degree of tumor differentiation.</s><s>These results are summarized in Table <ref type="table" target="#tab_6">4</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>KLK6 in Gastric Cancer</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Gastric cancer is one of the most aggressive cancer types that continues to have a daunting impact on global health <ref type="bibr" target="#b29">[16]</ref>.</s><s>Despite an overall decline in incidence over the past decades, gastric cancer remains the fourth most common type of cancer and the second leading cause of cancer-related death worldwide <ref type="bibr" target="#b31">[17]</ref>.</s><s>To date, surgery remains the only curative treatment.</s><s>For locally advanced disease, adjuvant or neoadjuvant therapy is usually implemented in combination with surgery.</s><s>Unfortunately, treatment for advanced or metastatic gastric cancer has seen little progress over the years, with the median survival being approximately 1 year <ref type="bibr" target="#b29">[16,</ref><ref type="bibr" target="#b31">17]</ref>.</s><s>Therefore, understanding the functions of new genes, unravelling novel therapeutic targets and developing drugs accordingly, especially for patients with advanced gastric cancer, is the current mainstay for gastric cancer research.</s></p><p><s>KLKs are an important family of proteases and numerous studies have characterized the functions of KLKs in different aspects of cancer and have explored their potential value as diagnostic or prognostic markers, as well as therapeutic targets <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>The best-known example is KLK3 (PSA), which is applied for the diagnosis and management of prostate cancer <ref type="bibr" target="#b31">[17]</ref>.</s><s>KLK6 is another key member of the family whose expression is upregulated in a variety of cancers, thereby influencing critical functional roles <ref type="bibr" target="#b19">[11,</ref><ref type="bibr" target="#b33">[18]</ref><ref type="bibr" target="#b35">[19]</ref><ref type="bibr" target="#b37">[20]</ref>.</s><s>Studies on ovarian and colon cancer model systems also showed that KLK6 promotes metastasis by inhibiting E-cadherin expression <ref type="bibr" target="#b19">[11,</ref><ref type="bibr" target="#b21">12]</ref>.</s><s>Despite this knowledge, the functional role of KLK6 in gastric cancer cells has not been fully elucidated.</s></p><p><s>A couple of previous studies have compared KLK6 expression in human gastric cancerous tissues and normal tissues and both studies revealed a higher level of KLK6 expression in cancerous gastric tissues than in normal tissues, shedding light on the expression and significance of KLK6 in this malignant disease <ref type="bibr" target="#b7">[5,</ref><ref type="bibr" target="#b35">19]</ref> findings, we first examined KLK6 expression in a panel of 4 different gastric cancer cell lines and 1 normal gastric epithelial cell line.</s><s>KLK6 expression was markedly higher in gastric cancer cells relative to normal cells (Fig. <ref type="figure">1</ref>).</s><s>Interestingly, 2 pro-metastasis factors VEGF and MMP9 showed a similar expression pattern across these cell lines (Fig. <ref type="figure">1</ref>).</s><s>In line with these in vitro observations, both mRNA and protein expression levels of KLK6 were drastically elevated in gastric cancer tissues compared to their adjacent normal counterparts (Fig. <ref type="figure" target="#fig_3">5A</ref>), which showed elevated VEGF and MMP9 expression levels (Fig. <ref type="figure" target="#fig_3">5B</ref> and Table <ref type="table" target="#tab_4">2</ref>).</s><s>Therefore, our results confirmed previous findings on both mRNA and protein levels in a large cohort of Chinese gastric cancer patients, and suggest that increased KLK6 expression is a common phenomenon in human gastric cancer and that it might serve as a diagnostic marker.</s></p><p><s>To investigate the functional significance of KLK6 in gastric cancer, we first utilized FACS to sort the gastric cancer cell line SGC-7901 into clones that expressed KLK6 in various degrees.</s><s>We then expanded 2 clones with distinct KLK6 expression confirmed by Western blot analysis (Fig. <ref type="figure">2A</ref>).</s><s>Compared to KLK6 low cells, KLK6 high cells exhibited significantly higher growth rate and colony forming ability (Fig. <ref type="figure">2B and C</ref>), as well as stronger migration and invasion potential (Figs. <ref type="figure" target="#fig_2">3 and 4</ref>).</s><s>These data were in line with the roles of KLK6 in other cancer types.</s><s>For example, KLK6 was shown to promote breast cancer cell invasiveness, which could be suppressed by a specifically engineered inhibitor of KLK6 <ref type="bibr" target="#b39">[21,</ref><ref type="bibr" target="#b41">22]</ref>.</s><s>Meanwhile, in ovarian and colon cancer cells, KLK6 was found to decrease E-cadherin expression and cell adhesion, thereby promoting tumor invasion and metastasis <ref type="bibr" target="#b19">[11,</ref><ref type="bibr" target="#b21">12]</ref>.</s><s>In squamous skin cancer, KLK6 was found to degrade extracellular matrix proteins, stimulate angiogenesis, and promote proliferation, migration, and invasion <ref type="bibr" target="#b17">[10]</ref>.</s><s>In our study, the fact that the expression of KLK6 was closely associated with the expression levels of VEGF and MMP9 in cell lines and in human gastric cancer tissues (Fig. <ref type="figure">1</ref> and Table <ref type="table" target="#tab_5">3</ref>) indicated that the effect of KLK6 in gastric cancer cells was possibly mediated, at least in part, by VEGF and MMP9.</s></p><p><s>An early report has linked KLK6 mRNA level with lymphatic invasion and OS rate in a cohort of Japanese gastric cancer patients <ref type="bibr" target="#b7">[5]</ref>, whereas a recent study observed no significant difference in serum KLK6 level among patients at various tumor stages <ref type="bibr" target="#b35">[19]</ref>.</s><s>Taking advantage of our cohort, we also examined the correlation of KLK6 expression with several key clinicopathological parameters in gastric cancer.</s><s>Importantly, our results revealed that positive KLK6 expression was significantly correlated with increased incidence of lymph node metastasis, higher grade of tumor differentiation and TNM staging, and poor OS in gastric cancer patients (Fig. <ref type="figure" target="#fig_3">5C</ref> and Table <ref type="table" target="#tab_6">4</ref>).</s><s>These findings, together with in vitro functional results, suggested that enhanced expression of KLK6 might play an important role in the progression of gastric cancer.</s></p><p><s>In conclusion, our study demonstrated that KLK6 promoted the growth, migration, and invasion of gastric cancer cells in vitro.</s><s>We also showed that KLK6 expression was elevated in gastric cancers compared to normal tissues, and it was significantly correlated with several critical clinicopathological parameters.</s><s>Future studies will address whether KLK6 can serve as a potential therapeutic target for gastric cancer by targeting its expression in both in vitro and in vivo models.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>KLK6Fig. 1 .Fig. 2 .</head><label>12</label><figDesc><div><p><s>Fig. 1.</s><s>Protein expression of KLK6, VEGF, and MMP9 in various gastric cancer and normal gastric epithelial cells.</s><s>KLK6 = kallikrein 6; VEGF = vascular endothelial growth factor; MMP9 = matrix metallopeptidase 9.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>KLK6Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. (A)Wound healing assay was performed using KLK6 low and KLK6 high cells.</s><s>The wound was imaged at 0, 24, and 48 hours after the scratch.</s><s>(B) Quantification of wound healing area and wound healing ratio (%) in (A).</s><s>KLK6 high = kallikrein 6-high; KLK6 low = kallikrein 6-low.</s><s>*Indicated value means statistical significance.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>KLK6Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. (A)Transwell invasion assay was performed to assess the invasive potential of KLK6 high and KLK6 low cells.</s><s>Cells were allowed to invade for 24 hours, and the inserts were then fixed and stained.</s><s>(B) Quantification of the invaded cells in (A).</s><s>KLK6 high = kallikrein 6-high; KLK6 low = kallikrein 6-low.</s><s>*Indicated value means statistical significance.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 5 .</head><label>5</label><figDesc><div><p><s>Fig. 5. (A) qPCR and western blot analyses of KLK6, VEGF, and MMP9 expression in gastric cancer and adjacent normal tissues.</s><s>(B) Immunohistochemical staining of KLK6, VEGF, and MMP9 in gastric cancer and adjacent normal tissues.</s><s>The a, c, and e are tumor tissues; b, d, and f are normal tissues.</s><s>(C) Kaplan-Meier curves suggesting that KLK6 − patients had a significantly better chance of survival than KLK6 + patients.</s><s>The χ 2 and P-values are indicated in the plot.</s><s>qPCR = quantitative polymerase chain reaction; KLK6 = kallikrein 6; VEGF = vascular endothelial growth factor; MMP9 = matrix metallopeptidase 9; mRNA = messenger RNA.</s><s>*Indicated value means statistical significance.</s></p></div></figDesc><graphic coords="8,72.75,347.56,73.22,54.79" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table</head><label></label><figDesc></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>.</head><label></label><figDesc><div><p><s>All patients provided informed consent under the guidelines approved by the Ethical Committee of People's Hospital of Zhengzhou.</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>e35 KLK6 in Gastric Cancer CellsTable 1 .</head><label>1</label><figDesc><div><p><s>Patient</s></p></div></figDesc><table><row><cell>distribution according to different characteristics</cell><cell></cell></row><row><cell>Characteristics</cell><cell>No. of patients (%)</cell></row><row><cell>Gender</cell><cell></cell></row><row><cell>Male</cell><cell>234</cell></row><row><cell>Female</cell><cell>92</cell></row><row><cell>Age (yr)</cell><cell></cell></row><row><cell>≥54.5</cell><cell>210</cell></row><row><cell>&lt;54.5</cell><cell>116</cell></row><row><cell>Tumor differentiation</cell><cell></cell></row><row><cell>Low</cell><cell>113</cell></row><row><cell>Moderate-high</cell><cell>213</cell></row><row><cell>TNM stage</cell><cell></cell></row><row><cell>Phase I</cell><cell>82</cell></row><row><cell>Phase II</cell><cell>114</cell></row><row><cell>Phase III</cell><cell>130</cell></row><row><cell>Lymph node metastases</cell><cell></cell></row><row><cell>Yes</cell><cell>136</cell></row><row><cell>No</cell><cell>190</cell></row><row><cell>TNM = tumor, node, and metastasis.</cell><cell></cell></row></table><note><p><s>online.org https://doi.org/10.5230/jgc.2018.18.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Comparison of KLK6, VEGF, and MMP9 staining between gastric cancer and normal tissues Indicated value means significant difference (P&lt;0.05).</s></p></div></figDesc><table><row><cell>Tissue type</cell><cell>Number of positively-stained samples</cell><cell>KLK6</cell><cell>VEGF</cell><cell>MMP9</cell></row><row><cell>Tumor</cell><cell>326</cell><cell>142 (43.56)*</cell><cell>173 (53.07)*</cell><cell>238 (73.01)*</cell></row><row><cell>Normal</cell><cell>326</cell><cell>26 (7.98)</cell><cell>57 (17.48)</cell><cell>44 (13.50)</cell></row><row><cell cols="2">Values are presented as number (%).</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">KLK6 = kallikrein 6; VEGF = vascular endothelial growth factor; MMP9 = matrix metallopeptidase 9.</cell><cell></cell><cell></cell></row></table><note><p><s>*</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Concordant expression of KLK6 with VEGF and MMP9 expression in human gastric cancer samples</s></p></div></figDesc><table><row><cell>KLK6</cell><cell>VEGF</cell><cell></cell><cell>r-value</cell><cell>P-value</cell><cell>MMP9</cell><cell></cell><cell>r-value</cell><cell>P-value</cell></row><row><cell></cell><cell>+</cell><cell>−</cell><cell></cell><cell></cell><cell>+</cell><cell>−</cell><cell></cell><cell></cell></row><row><cell>+</cell><cell>100</cell><cell>73</cell><cell>0.305</cell><cell>&lt;0.01</cell><cell>125</cell><cell>17</cell><cell>0.297</cell><cell>&lt;0.01</cell></row><row><cell>−</cell><cell>42</cell><cell>111</cell><cell></cell><cell></cell><cell>113</cell><cell>71</cell><cell></cell><cell></cell></row><row><cell cols="2">Values are presented as number (%).</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="6">KLK6 = kallikrein 6; VEGF = vascular endothelial growth factor; MMP9 = matrix metallopeptidase 9.</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>. To further validate the nature of these Correlation of KLK6 expression with major clinicopathological parameters</s></p></div></figDesc><table><row><cell>364</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">https://jgc-online.org https://doi.org/10.5230/jgc.2018.18.e35 KLK6 in Gastric Cancer Cells</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">KLK6 in Gastric Cancer Cells</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>The authors would like to thank the colleagues at The First Affiliated Hospital and School of Basic Medicine of Zhengzhou University for their help, and the pathologists at the People's Hospital of Zhengzhou for their assistance.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The new human tissue kallikrein gene family: structure, function, and association to disease</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Yousef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Diamandis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="184" to="204" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The emerging roles of human tissue kallikreins in cancer</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Borgoño</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Diamandis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="876" to="890" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc1474</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tesikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kristian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Maelandsmo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="E2572" to="E2581" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1304318110</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Stamey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Mcneal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Freiha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Redwine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">317</biblScope>
			<biblScope unit="page" from="909" to="916" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJM198710083171501</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer</title>
		<author>
			<persName><forename type="first">H</forename><surname>Nagahara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mimori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Utsunomiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Barnard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ohira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hirakawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="6800" to="6806" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-05-0943</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers</title>
		<author>
			<persName><forename type="first">R</forename><surname>Schuster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Max</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Heufelder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Thilo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gröne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="219" to="227" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.11547</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">V</forename><surname>Nathalie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chris</forename><forename type="middle">P</forename><surname>Serge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Catherine</forename><forename type="middle">C</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Claire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Mol Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="4014" to="4022" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1582-4934.2009.00763.x</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Shan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scorilas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Katsaros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Diamandis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="362" to="372" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjc.6603556</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Kallikreinrelated peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vakrakou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Devetzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Papachristopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malachias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scorilas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xynopoulos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Chem</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="page" from="1105" to="1117" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1515/hsz-2014-0166</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion</title>
		<author>
			<persName><forename type="first">B</forename><surname>Klucky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Teurich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hartenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Breuhahn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="8198" to="8206" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-07-0607</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="2608" to="2619" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1002/cncr.25841</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sawada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Radjabi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Bhaskar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Kistner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tretiakova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="2329" to="2339" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-07-5167</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Bae</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="85332" to="85348" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.13352</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer</title>
		<author>
			<persName><forename type="first">Masoumi</forename><surname>Moghaddam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Amini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Pourgholami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Metastasis Rev</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="143" to="162" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10555-011-9337-5</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Matrix metalloproteinases and tumor metastasis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Deryugina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Quigley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Metastasis Rev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="9" to="34" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10555-006-7886-9</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Gastric cancer review</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Carcas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Carcinog</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">14</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.4103/1477-3163.146506</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Gastric cancer</title>
		<author>
			<persName><forename type="first">E</forename><surname>Van Cutsem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sagaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Topal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Haustermans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Prenen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="2654" to="2664" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(16)30354-3</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Kallikrein-related peptidases in lung diseases</title>
		<author>
			<persName><forename type="first">Lenga</forename><surname>Ma Bonda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Iochmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Magnen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Courty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Reverdiau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Chem</title>
		<imprint>
			<biblScope unit="volume">399</biblScope>
			<biblScope unit="page" from="959" to="971" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1515/hsz-2018-0114</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Upregulation and secretion of kallikreinrelated peptidase 6 (KLK6) in gastric cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="731" to="738" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-011-0267-1</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier</title>
		<author>
			<persName><forename type="first">K</forename><surname>Oikonomopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Diamandis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Hollenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Chem</title>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="299" to="310" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1515/bc.2010.038</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sananes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shahar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hockla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Vita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="12663" to="12680" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.RA117.000871</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Sidiropoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pampalakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sotiropoulou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Oncol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="993" to="1007" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title/>
		<author>
			<persName><surname>Pubmed | Crossref</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.molonc.2016.03.008</idno>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
